Different vaccines. Do you remember when the vaccines was rolled out under Trump how it had to be kept cold? Hauled around by army(?) in refrigerated trucks.
We say that now but the majority of people were fooled. It seemed that the only people I knew who refused to take the vaccine were those who had degrees in a hard science, not biology, or healthy men less than 50 yo. It was very disheartening.
My thought process, armed forces were involved, those first vaccines that were rolled out were fine, Trump left office and those vaccines were immediately “updated” by bad actors. I don’t have proof, but I do have a timeline.
The follow g is from a conversation with Grok. I remember all of this happening, but it was easier to get Grok to find the receipts.
Yes, there were articles about the involvement of the armed forces in the distribution of the Covid vaccine when it first became available. According to various reports, the U.S. military played a role in logistics, specifically in the transportation and distribution of the vaccines. For instance, it was noted that military personnel were involved in ensuring the vaccines reached various parts of the country, particularly under the coordination of Operation Warp Speed.
Here are the citations for this information:
Information on the military's role in vaccine logistics was found in articles from BBC News and Defense.gov.
Posts on X (formerly Twitter) from official U.S. Army accounts also highlighted the initial distribution efforts, including the involvement of military personnel in administering vaccines at military bases.
Yes, the first Covid vaccines were handled differently in several key aspects compared to those that came out later. Here's how, based on the information available:
Development and Approval:
The initial vaccines, like those from Pfizer-BioNTech and Moderna, were developed at an unprecedented speed due to the global health emergency. They utilized mRNA technology, which was relatively new for widespread use in human vaccines. These vaccines went through an expedited process under Emergency Use Authorization (EUA) by the FDA, which allowed for faster deployment without skipping any trial phases but did compress timelines. The process was also supported by overlapping clinical trial phases and significant resource allocation from the outset.
Distribution and Logistics:
The distribution of the first vaccines involved unique logistical challenges due to their storage requirements. For instance, the Pfizer-BioNTech vaccine required storage at ultra-cold temperatures (-80°C to -60°C), necessitating specialized freezers and logistics, which was not common for other vaccines. This led to the military's involvement in logistics and distribution, particularly through Operation Warp Speed, to ensure timely and widespread delivery.
Public Perception and Acceptance:
Early vaccines faced public scrutiny and skepticism due to the speed of their development. There was significant effort in public health campaigns to clarify the safety and efficacy of these vaccines, addressing concerns over the expedited process. This was different from later vaccines where public familiarity with Covid vaccines had already been established, although hesitancy and misinformation continued to be issues.
Vaccine Composition and Variants:
The initial vaccines were designed to combat the original strain of SARS-CoV-2. As new variants emerged, later vaccines were updated to address these variants more effectively. For example, vaccines in the 2024-2025 season were updated to target specific variants like KP.2 and JN.1, which were not considerations for the first vaccines.
Monitoring and Safety:
The safety monitoring of the initial vaccines was intense, with systems like the Vaccine Adverse Event Reporting System (VAERS) and others being particularly vigilant for any adverse effects due to the novelty of mRNA vaccines and the scale of deployment. Over time, as data accumulated, monitoring systems continued but with adjustments to focus on newly identified risks or patterns, like myocarditis in young males.
In summary, the first vaccines were unique in their rapid development, stringent cold chain logistics, public perception management, and the initial focus on the original virus strain, setting them apart from later iterations which benefited from this groundwork in terms of process, public trust, and variant-specific adjustments.
Different vaccines. Do you remember when the vaccines was rolled out under Trump how it had to be kept cold? Hauled around by army(?) in refrigerated trucks.
You mean the pfizer vs moderna?
Nope
Well, covid being fake and all I wonder what anyone would want to inject. Even if it came from Trump himself.
We say that now but the majority of people were fooled. It seemed that the only people I knew who refused to take the vaccine were those who had degrees in a hard science, not biology, or healthy men less than 50 yo. It was very disheartening.
care to elaborate on this? you give the impression that you know more
My thought process, armed forces were involved, those first vaccines that were rolled out were fine, Trump left office and those vaccines were immediately “updated” by bad actors. I don’t have proof, but I do have a timeline. The follow g is from a conversation with Grok. I remember all of this happening, but it was easier to get Grok to find the receipts. Yes, there were articles about the involvement of the armed forces in the distribution of the Covid vaccine when it first became available. According to various reports, the U.S. military played a role in logistics, specifically in the transportation and distribution of the vaccines. For instance, it was noted that military personnel were involved in ensuring the vaccines reached various parts of the country, particularly under the coordination of Operation Warp Speed.
Here are the citations for this information:
Information on the military's role in vaccine logistics was found in articles from BBC News and Defense.gov.
Posts on X (formerly Twitter) from official U.S. Army accounts also highlighted the initial distribution efforts, including the involvement of military personnel in administering vaccines at military bases.
Yes, the first Covid vaccines were handled differently in several key aspects compared to those that came out later. Here's how, based on the information available:
Development and Approval: The initial vaccines, like those from Pfizer-BioNTech and Moderna, were developed at an unprecedented speed due to the global health emergency. They utilized mRNA technology, which was relatively new for widespread use in human vaccines. These vaccines went through an expedited process under Emergency Use Authorization (EUA) by the FDA, which allowed for faster deployment without skipping any trial phases but did compress timelines. The process was also supported by overlapping clinical trial phases and significant resource allocation from the outset.
Distribution and Logistics: The distribution of the first vaccines involved unique logistical challenges due to their storage requirements. For instance, the Pfizer-BioNTech vaccine required storage at ultra-cold temperatures (-80°C to -60°C), necessitating specialized freezers and logistics, which was not common for other vaccines. This led to the military's involvement in logistics and distribution, particularly through Operation Warp Speed, to ensure timely and widespread delivery.
Public Perception and Acceptance: Early vaccines faced public scrutiny and skepticism due to the speed of their development. There was significant effort in public health campaigns to clarify the safety and efficacy of these vaccines, addressing concerns over the expedited process. This was different from later vaccines where public familiarity with Covid vaccines had already been established, although hesitancy and misinformation continued to be issues.
Vaccine Composition and Variants: The initial vaccines were designed to combat the original strain of SARS-CoV-2. As new variants emerged, later vaccines were updated to address these variants more effectively. For example, vaccines in the 2024-2025 season were updated to target specific variants like KP.2 and JN.1, which were not considerations for the first vaccines.
Monitoring and Safety: The safety monitoring of the initial vaccines was intense, with systems like the Vaccine Adverse Event Reporting System (VAERS) and others being particularly vigilant for any adverse effects due to the novelty of mRNA vaccines and the scale of deployment. Over time, as data accumulated, monitoring systems continued but with adjustments to focus on newly identified risks or patterns, like myocarditis in young males.
In summary, the first vaccines were unique in their rapid development, stringent cold chain logistics, public perception management, and the initial focus on the original virus strain, setting them apart from later iterations which benefited from this groundwork in terms of process, public trust, and variant-specific adjustments.